Implementing non-invasive prenatal testing into publicly funded antenatal screening services for Down syndrome and other conditions in Aotearoa New Zealand
Abstract Background Non-invasive prenatal testing (NIPT) is a relatively new screen for congenital conditions – specifically, common fetal aneuploidies including Down Syndrome. The test is based on isolating freely circulating fragments of fetal-placental DNA that is present in the mother’s blood. N...
Main Authors: | Sara Filoche, Fiona Cram, Bev Lawton, Angela Beard, Peter Stone |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | BMC Pregnancy and Childbirth |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12884-017-1535-x |
Similar Items
-
Identifying the barriers and enablers in the implementation of the New Zealand and Australian Antenatal Corticosteroid Clinical Practice Guidelines
by: E. L. Mc Goldrick, et al.
Published: (2016-10-01) -
Adapting an equity-focused implementation process framework with a focus on ethnic health inequities in the Aotearoa New Zealand context
by: Papillon Gustafson, et al.
Published: (2024-01-01) -
Non-Invasive Prenatal Testing: Review of Ethical, Legal and Social Implications
by: Haidar, Hazar, et al.
Published: (2016-02-01) -
Women’s experiences with non-invasive prenatal testing in Switzerland: a qualitative analysis
by: Mirriam Tyebally Fang, et al.
Published: (2023-10-01) -
Integrated Care in Aotearoa New Zealand 2008–2020
by: Jacqueline Cumming, et al.
Published: (2021-11-01)